Literature DB >> 17949716

Ataxin-2 mediated cell death is dependent on domains downstream of the polyQ repeat.

Hiushan Ng1, Stefan-M Pulst, Duong P Huynh.   

Abstract

Spinocerebellar ataxia 2 (SCA2) belongs to the group of neurodegenerative diseases caused by expansion of a polyglutamine (polyQ) domain. Overexpression of mutant ataxin-2 causes cell death and Golgi dispersion in cell culture as well as morphologic and functional changes in mouse models. To further define the mechanism of ataxin-2 induced cell death, we compared the cytotoxic effects of different domains of normal and mutant ataxin-2. N-terminal truncated ataxin-2(N) with expanded polyQ repeats did not form intranuclear inclusion and was less cytotoxic than the corresponding full-length ataxin-2. Ataxin-2(del42)[Q22], which lacks 42 amino acids (aa) within the Lsm-associated domain (LsmAD) necessary for Golgi localization, showed a diffuse cytoplasmic localization and was more toxic than wild type ataxin-2[Q22]. Mutant ataxin-2(del42)[Q108] displayed the same toxicity as ataxin-2[Q108], but did not disperse the Golgi apparatus to the extent seen with full-length mutant proteins. These observations confirm that ataxin-2 cytotoxicity increases with increasing polyQ expansion and Golgi dispersion and indicate that, in contrast to other polyQ diseases, N-terminal fragments containing the polyQ repeat are less toxic than full-length ataxin-2. Deletion of 42 aa in the Lsm-AD in ataxin-2 results in cytotoxicity without significant abnormalities in the Golgi apparatus. These findings suggest that the C-terminal domains are important for ataxin-2 cytotoxicity and that Golgi abnormalities may not be primary in the pathogenic process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949716      PMCID: PMC2186298          DOI: 10.1016/j.expneurol.2007.07.023

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  34 in total

Review 1.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  [The function of spinocerebellar ataxia type 2 (SCA2) gene product, ataxin-2 and the mechanism of pathogenesis for SCA2].

Authors:  K Sanpei
Journal:  Nihon Rinsho       Date:  1999-04

3.  Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.

Authors:  Stefan-M Pulst; Nieves Santos; Dai Wang; Huiying Yang; Duong Huynh; Luis Velazquez; K Pattie Figueroa
Journal:  Brain       Date:  2005-07-06       Impact factor: 13.501

4.  Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes.

Authors:  Terrence F Satterfield; Leo J Pallanck
Journal:  Hum Mol Genet       Date:  2006-07-11       Impact factor: 6.150

5.  Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies.

Authors:  R Estrada; J Galarraga; G Orozco; A Nodarse; G Auburger
Journal:  Acta Neuropathol       Date:  1999-03       Impact factor: 17.088

6.  An integrative approach to gain insights into the cellular function of human ataxin-2.

Authors:  Markus Ralser; Mario Albrecht; Ute Nonhoff; Thomas Lengauer; Hans Lehrach; Sylvia Krobitsch
Journal:  J Mol Biol       Date:  2004-12-10       Impact factor: 5.469

7.  Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death.

Authors:  Duong P Huynh; Dung T Nguyen; Johannes B Pulst-Korenberg; Alexis Brice; Stefan-M Pulst
Journal:  Exp Neurol       Date:  2006-11-09       Impact factor: 5.330

8.  Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2.

Authors:  D P Huynh; M R Del Bigio; D H Ho; S M Pulst
Journal:  Ann Neurol       Date:  1999-02       Impact factor: 10.422

9.  Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

Authors:  I A Klement; P J Skinner; M D Kaytor; H Yi; S M Hersch; H B Clark; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

10.  The mouse SCA2 gene: cDNA sequence, alternative splicing and protein expression.

Authors:  T Nechiporuk; D P Huynh; K Figueroa; S Sahba; A Nechiporuk; S M Pulst
Journal:  Hum Mol Genet       Date:  1998-08       Impact factor: 6.150

View more
  5 in total

1.  Conserved role for Ataxin-2 in mediating endoplasmic reticulum dynamics.

Authors:  Urko Del Castillo; Megan M Gnazzo; Christopher G Sorensen Turpin; Ken C Q Nguyen; Emily Semaya; Yuwan Lam; Matthew A de Cruz; Joshua N Bembenek; David H Hall; Blake Riggs; Vladimir I Gelfand; Ahna R Skop
Journal:  Traffic       Date:  2019-05-08       Impact factor: 6.215

2.  ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications.

Authors:  Michael P Hart; Aaron D Gitler
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

3.  ETS1 regulates the expression of ATXN2.

Authors:  Daniel R Scoles; Lance T Pflieger; Khanh K Thai; Stephen T Hansen; Warunee Dansithong; Stefan-M Pulst
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

Review 4.  Ataxin-2: From RNA Control to Human Health and Disease.

Authors:  Lauren A Ostrowski; Amanda C Hall; Karim Mekhail
Journal:  Genes (Basel)       Date:  2017-06-05       Impact factor: 4.096

Review 5.  From pathways to targets: understanding the mechanisms behind polyglutamine disease.

Authors:  Jonasz Jeremiasz Weber; Anna Sergeevna Sowa; Tina Binder; Jeannette Hübener
Journal:  Biomed Res Int       Date:  2014-09-21       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.